Recent studies demonstrated that the double rearrangement (double hit) of the MYC and BCL2 genes and the double expression of the MYC and BCL2 proteins were associated with a poor prognosis for patients with nodal DLBCL.7, 8, 9, 10 However, the clinical impact of the double expression of MYC and BCL2 on PG-DLBCL remains unknown. Here, BCL2 is linked to diffuse large B-cell lymphoma.